If anyone wants to push the envelope in OTC, gotta put a

New Post Public Reply Private Reply Replies (3) Message Board
DJknows DJknows #26901
486
If anyone wants to push the envelope in OTC, gotta put a CEO's feet to the fire... just tried, doesn't cost me a thing:

https://twitter.com/on4company/status/1096035769809100800


@djknows1
now
More
Replying to @on4company
Simple yes or no will do... did you actually file the necessary form with TA to get SR done in 24-48 hours? Please be honest and candid for a change ... with truth and reality... not just your own 'intention' or wish! TIA


If anyone has not had a really horrendous experience in OTC... if one isn't familiar with the ins-and-outs of OTC or regulatory processes... if one is flipping... then they will likely not question the CEO. Everyone else should be questioning the CEO (period).

Believe it when I say a/the CEO has soooo much control with all of it in OTC (not all control of course as others especially regulators/clients are or can be involved)...

Even when you give them funds, they can still screw it up....

I do not bet the farm or what I cannot afford to lose so I'm spouting the truth (believe it or not it's no skin off my back... I can walk away from these message boards and OTC if I want)... and it's not out of frustration even though I know this can be frustrating... maybe my opinion but I, as a shareholder, am entitled to my opinion whether anyone likes it or not.

I want to hold my CEO accountable... and if this is the only way... it's the only way.... my money, my word... yes even with ONCI and on the great IHang... it's all about what you know, your money and whether you believe.

Have a great weekend and




Very best to all with ONCI/HEXA !





On4 Communications (ONCI) Stock Research Links

ONCI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading